Seema Gulia (@seemagulia1) 's Twitter Profile
Seema Gulia

@seemagulia1

ID: 1219445663366352897

calendar_today21-01-2020 02:25:06

23 Tweet

205 Followers

74 Following

ACTREC-TMC (@actrec_tmc) 's Twitter Profile Photo

Dr Sudhir Nair & colleagues from Tata Memorial Hospital ACTREC-TMC provide compelling evidence of effectiveness & accuracy of symptom-based telephonic follow-up in cancer patients in JAMA Otolaryngology – Head & Neck Surgery ! Hugely important at all times but especially during #COVID jamanetwork.com/journals/jamao…

Dr Sudhir Nair &amp; colleagues from <a href="/TataMemorial/">Tata Memorial Hospital</a> <a href="/ACTREC_TMC/">ACTREC-TMC</a> provide compelling evidence of effectiveness &amp; accuracy of symptom-based telephonic follow-up in cancer patients in <a href="/JAMAOto/">JAMA Otolaryngology – Head & Neck Surgery</a> ! Hugely important at all times but especially during #COVID 
jamanetwork.com/journals/jamao…
ACTREC-TMC (@actrec_tmc) 's Twitter Profile Photo

Concerning cardiac effects of #COVID ! Almost 60% patients, many mild disease, had heart inflammation on MRI after recovery! Even if very small fraction have clinical problems, will be large no., given millions infected! Need for vigilance! JAMA Cardiology jamanetwork.com/journals/jamac…

Concerning cardiac effects of #COVID ! Almost 60% patients, many mild disease, had heart inflammation on MRI after recovery! Even if very small fraction have clinical problems, will be large no., given millions infected! Need for vigilance! <a href="/JAMACardio/">JAMA Cardiology</a>  
jamanetwork.com/journals/jamac…
Tata Memorial Hospital (@tatamemorial) 's Twitter Profile Photo

In India, 1 in 28 women will develop breast cancer during her lifetime. This #BreastCancerAwarenessMonth Dr Sudeep Gupta, Director ACTREC-TMC tells us how we can reduce the risk of #breastcancer. Tata Memorial Hospital

Seema Gulia (@seemagulia1) 's Twitter Profile Photo

First line maintenance PARPi in ovarian cancer improves PFS ✅ in BRCA mutant and HRD positive patients and NOT in HRD negatives ❌. Choosing wisely is the way forward !esmoopen.com/article/S2059-… Pramesh CS ACTREC-TMC ICMR

Seema Gulia (@seemagulia1) 's Twitter Profile Photo

Updated IPD meta-analysis (including ATHENA-MONO data) on efficacy of maintenance PARP inhibitors in newly diagnosed advanced epithelial ovarian cancers,did not show substantial benefit of PARP inhibitors in HRD negative tumors ACTREC-TMC Susana Banerjee Dr Amol Akhade ESMO Open

Updated IPD meta-analysis (including ATHENA-MONO data) on efficacy of maintenance PARP inhibitors in newly diagnosed advanced epithelial ovarian cancers,did not show substantial benefit of PARP inhibitors in HRD negative tumors <a href="/ACTREC_TMC/">ACTREC-TMC</a> <a href="/BanerjeeSusana/">Susana Banerjee</a> <a href="/SuyogCancer/">Dr Amol Akhade</a> <a href="/ESMO_Open/">ESMO Open</a>
Seema Gulia (@seemagulia1) 's Twitter Profile Photo

The long time debate on the use of platinum in TNBC is finally settled ! Congratulations ACTREC-TMC, Tata Memorial Hospital, entire breast DMG for this landmark trial. Platinum improves survival in premenopausal TNBC.

The long time debate on the use of platinum in TNBC is finally settled ! Congratulations <a href="/ACTREC_TMC/">ACTREC-TMC</a>, <a href="/TataMemorial/">Tata Memorial Hospital</a>, entire breast DMG for this landmark trial. Platinum improves survival in premenopausal TNBC.
Seema Gulia (@seemagulia1) 's Twitter Profile Photo

Be selective in subjecting patients to Secondary Cytoreduction ! Incomplete surgery is detrimental. ijgc.bmj.com/content/early/…

Be selective in subjecting patients to Secondary Cytoreduction ! 
Incomplete surgery is detrimental. ijgc.bmj.com/content/early/…